Johnson & Johnson Development Corporation, the in-house venture arm of the US-based consumer and medical goods maker, has linked up again with venture capital firm De Novo Ventures and joined the second round of financing for Astute Medical, a San Diego-based medical diagnostics company focused on high-risk conditions. Astute raised $26.5m in series B…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
